Publications & Resources

CDC research indicates that inappropriate prescribing of antibiotics for respiratory conditions is highest in the Urgent Care Setting at 45.7% and second highest in the Emergency Department at 24.6%. Taking the time to educate patients in these settings regarding the difference between a viral illness that does not require antibiotics and a bacterial infection is a key to managing this issue.

A cornerstone of the quality of care provided at any healthcare organization is a culture that provides for the safety of patients and promotes an environment where staff and providers feel comfortable in raising issues or concerns.

MLMIC is proud to be a sponsor of the upcoming New York State Neurological Society’s (NYSNS) Annual Winter Meeting on Saturday, January 5, 2019, at the Stewart Hotel on 31st Street and 7th Avenue in Manhattan. The event, which was organized by the NYSNS, is open to physicians in all medical specialties.

MLMIC Insurance Company has received an A+ (Superior) Financial Strength Rating and a Long-Term Issuer Credit Rating of “aa-” from AM Best.

ONC has released a draft strategy it believes will lessen the regulatory and administrative burden of health information technologies, such as EHRs. MLMIC encourages all insured stakeholders to take this opportunity to offer their input.

As a supporter of the 72nd PostGraduate Assembly in Anesthesiology December 7-11, 2018, MLMIC will have an exhibit (Booth 107) and deliver a talk on legal challenges and malpractice trends specific to anesthesiologists.

In an effort to provide the healthcare industry with information regarding safety topics that warrant the attention of facilities and providers, ECRI Institute publishes an annual list: Top Ten Health Technology Hazards. The 2019 list, available here, “represents problems that can be avoided or risks that can be minimized through careful management of technologies.”

MLMIC’s Q3 financials show continued strength and stability for New York’s leading medical liability insurer. In a consistently challenging insurance marketplace, it is reassuring to know that MLMIC is sound and ready to serve its policyholders.

The Fall 2018 edition of MLMIC’s Case Review describes how lack of communication impacts patient care, including diagnostic errors and treatment delays.

Berkshire Hathaway CEO Warren Buffett and MLMIC Chairman of the Board James Reed, M.D., discuss the future of healthcare and MLMIC’s role protecting New York physicians.